Market Place
Sourcing Support
Kintor Pharma and Etana`s Collaboration on Pruxelutamide`s COVID-19 Project
14 Jun 2022 //
ASIAONE
Kintor`s Proxalutamide Showed Reduction in Hospitalization/Mortality in COVID-19
05 Apr 2022 //
PRNEWSWIRE
Kintor Pharma Begins Dosing in Phase III Clinical Trial of Proxalutamide
11 Feb 2022 //
PRNEWSWIRE
Kintor`s interim analysis of COVID treatment trial misses statistical criteria
28 Dec 2021 //
REUTERS
Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients
05 Oct 2021 //
PHARMABIZ
Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients
05 Oct 2021 //
PHARMABIZ
Kintor Pharma Begins Patient Dosing in Phase III Trial of Proxalutamide
04 Oct 2021 //
PRNEWSWIRE
Chinese pharma to commercialize Proxalutamide for COVID-19 in Indonesia
25 Aug 2021 //
BIOSPECTRUM ASIA
Completion of Patients` Recruitment for Proxalutamide`s COVID-19 Study
22 Feb 2021 //
PRNEWSWIRE
Kintor Pharma completes patient recruitment in clinical trial of proxalutamide
22 Feb 2021 //
PHARMABIZ
Brazil approves trial of Kintor’s Proxalutamide in Covid-19 patients
29 Jan 2021 //
CLINICALTRIALSARENA
Kintor Proxalutamide`s COVID-19 Clinical Trial Shows Significant Reduction
11 Dec 2020 //
PRNEWSWIRE
Kintor Pharmaceutical`s COVID-19 Clinical Trials for Proxalutamide
29 Oct 2020 //
BIOSPACE
Kintor completes $240M IPO; WuXi Biologics is opening a Boston plant
19 May 2020 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.